- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
100
Most Popular Stocks on the market
100 companies
Swedish Orphan Biovitrum
Market Cap: SEK 96.2b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 276.80
7D
0.4%
1Y
-14.9%
Camurus
Market Cap: SEK 39.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 666.50
7D
-4.2%
1Y
2.9%
BioArctic
Market Cap: SEK 25.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 290.80
7D
3.5%
1Y
78.1%
AddLife
Market Cap: SEK 21.9b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 179.30
7D
-4.5%
1Y
13.2%
Bonesupport Holding
Market Cap: SEK 18.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 287.60
7D
-5.7%
1Y
-7.2%
Vitrolife
Market Cap: SEK 17.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 128.30
7D
-3.9%
1Y
-49.0%
BioGaia
Market Cap: SEK 11.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 109.40
7D
3.6%
1Y
-3.5%
MedCap
Market Cap: SEK 8.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 553.00
7D
-9.3%
1Y
9.7%
Swedencare
Market Cap: SEK 5.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 33.00
7D
-9.8%
1Y
-22.4%
Flerie
Market Cap: SEK 3.3b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 42.30
7D
2.3%
1Y
-0.5%
Hansa Biopharma
Market Cap: SEK 3.1b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 36.82
7D
19.9%
1Y
-7.2%
Vicore Pharma Holding
Market Cap: SEK 2.8b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 12.14
7D
20.7%
1Y
73.4%
Cereno Scientific
Market Cap: SEK 2.6b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally.
CRNO B
SEK 8.83
7D
6.1%
1Y
22.6%
Xspray Pharma
Market Cap: SEK 2.5b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 59.60
7D
13.7%
1Y
18.7%
Devyser Diagnostics
Market Cap: SEK 2.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 139.40
7D
-11.7%
1Y
2.1%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.54
7D
2.8%
1Y
26.2%
BioInvent International
Market Cap: SEK 2.0b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 29.90
7D
-4.5%
1Y
-37.5%
Dicot Pharma
Market Cap: SEK 1.7b
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.86
7D
1.3%
1Y
418.1%
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 11.92
7D
1.7%
1Y
173.4%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 23.00
7D
-8.4%
1Y
-17.6%
Diamyd Medical
Market Cap: SEK 1.5b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 11.00
7D
0%
1Y
-21.8%
BICO Group
Market Cap: SEK 1.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 20.64
7D
-4.3%
1Y
-51.9%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 20.80
7D
4.5%
1Y
107.4%
Oncopeptides
Market Cap: SEK 1.1b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.69
7D
-1.4%
1Y
113.9%
Orexo
Market Cap: SEK 1.0b
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 29.50
7D
5.0%
1Y
112.2%
Infant Bacterial Therapeutics
Market Cap: SEK 937.6m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 69.60
7D
2.2%
1Y
109.6%
Cinclus Pharma Holding
Market Cap: SEK 757.6m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 16.28
7D
-5.7%
1Y
-41.9%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Cantargia
Market Cap: SEK 660.1m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 2.66
7D
-7.7%
1Y
-19.1%
Xbrane Biopharma
Market Cap: SEK 626.2m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.25
7D
-6.7%
1Y
36.4%
Enzymatica
Market Cap: SEK 577.7m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 2.38
7D
1.3%
1Y
15.5%
FluoGuide
Market Cap: SEK 524.4m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 38.50
7D
0.3%
1Y
-5.3%
Guard Therapeutics International
Market Cap: SEK 453.8m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 22.50
7D
0.9%
1Y
-18.5%
Ascelia Pharma
Market Cap: SEK 400.3m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.45
7D
-9.8%
1Y
45.3%
Moberg Pharma
Market Cap: SEK 400.0m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.51
7D
-5.2%
1Y
-15.7%
Magle Chemoswed Holding
Market Cap: SEK 386.1m
Engages in research and development of pharmaceutical and medical device products in Sweden.
MAGLE
SEK 18.70
7D
-6.5%
1Y
-51.6%